This Study Aims to Evaluate the Safety, Tolerability, and Immunogenicity of the Adjuvanted Trivalent Subunit Influenza Vaccine and the Non-Adjuvanted Trivalent Subunit Influenza Vaccine Compared to the Non-Adjuvanted Trivalent Split Influenza Vaccine in Children 6 to \< 72 Months of Age.
Buenos Aires, Argentina
Buenos Aires, Argentina
Córdoba, Argentina
Córdoba, Argentina
Córdoba, Argentina
Cuidad Automa de Beunos Aires, Argentina
Mendoza, Argentina
Villa Nueva, Argentina